This is a clinical practice guideline on the management of adult patients with glioblastoma. The guideline provides treatment recommendations and discusses the prognostic value of MGMT promoter methylation. Surgery, external beam radiation, and chemotherapy are discussed as treatment options. Outcomes of interest include survival rates and quality of life.